Article

Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockade

2026-07-24

Abstract excerpt

<h4>Background</h4> Ovarian cancer (OvCa) ranks as the most lethal gynecological malignancy in women worldwide. This complex disease, which can develop independently of a woman’s age, is characterized by late diagnosis, pronounced tumor heterogeneity, and an immunosuppressive tumor microenvironment (TME). Incremental diagnostic tools that could better inform clinicians on potential therapy resistance or subsets o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 904c222b-6a29-5e3f-ba86-b7830d7b7308
DOI: 10.64898/2026.07.21.739796

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockadeDOI 10.64898/2026.07.21.739796Read

Identification an novel classification and nomogram of programmed cell-death patterns for investigating the immune microenvironment and prognosis of postoperative ovarian cancer patientsSemantic proximity Read

Immunotherapeutic Approaches in Ovarian CancerSemantic proximity Read

Identification machine learning-based model of programmed cell-death patterns for investigating the immune microenvironment and prognosis of ovarian cancer patients after surgery and providing therapeutic strategiesSemantic proximity Read

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.Semantic proximity Read

The mutational load and a T-cell inflamed tumor phenotype identify ovarian cancer patients rendering tumor-reactive T cells from PD-1+ tumor-infiltrating lymphocytesSemantic proximity Read

Enhancing Patient Lymphocyte Response to Peritoneal Malignancies Using a Personalized Immunocompetent Microfluidic Co-Culture PlatformSemantic proximity Read

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read

New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer.Semantic proximity Read

<i>Ex vivo</i> quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chipSemantic proximity Read

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in Arm A of the NSGO-OV-UMB1/ENGOT-OV30 trialSemantic proximity Read

The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free intervalSemantic proximity Read

HO-3867 mediated modulation of Extracellular vesicles and Tumor microenvironment: A novel immunotherapeutic strategy for ovarian cancerSemantic proximity Read